Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 600329.SS · Stock Open Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in new tab
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Analysis (600329.SS)
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited a good investment? Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) is currently trading at 41.20 CNY.
In terms of valuation, the stock trades at a P/E ratio of 33.62. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is expected to release its next earnings report on Oct. 26, 2026. The market consensus estimate for Forward EPS is 1.81.
For income investors, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited pays a dividend yield of 11.63%. With a payout ratio of 221%, the dividend appears to be under pressure.
Investor FAQ
Does Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited pay a dividend?
Yes, it pays an annual dividend of 4.79 CNY (11.63% yield).
What asset class is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited?
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Oct. 26, 2026. The company currently has a trailing EPS of 1.22.
Company Profile
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.
| Year | Total Dividends |
|---|---|
| ▸2027 |
4.79 CNY
|
| July 15, 2027 (estimated) | 2.3400 |
| Feb. 12, 2027 (estimated) | 2.4500 |
| ▸2026 |
4.79 CNY
|
| July 10, 2026 | 2.3400 |
| Feb. 12, 2026 | 2.4500 |
| ▸2025 |
1.28 CNY
|
| July 4, 2025 | 1.2800 |
| ▸2024 |
1.28 CNY
|
| July 12, 2024 | 1.2800 |
| ▸2023 |
1.12 CNY
|
| June 6, 2023 | 1.1200 |
| ▸2022 |
0.50 CNY
|
| June 2, 2022 | 0.5000 |
| ▸2021 |
0.30 CNY
|
| June 24, 2021 | 0.3000 |
| ▸2020 |
0.30 CNY
|
| June 24, 2020 | 0.3000 |
| ▸2019 |
0.22 CNY
|
| July 15, 2019 | 0.2200 |
| ▸2018 |
0.20 CNY
|
| July 13, 2018 | 0.2000 |
| ▸2017 |
0.15 CNY
|
| July 14, 2017 | 0.1500 |
| ▸2016 |
0.25 CNY
|
| Dec. 23, 2016 | 0.1000 |
| July 15, 2016 | 0.1500 |
| ▸2015 |
0.15 CNY
|
| June 1, 2015 | 0.1500 |
| ▸2014 |
0.05 CNY
|
| July 15, 2014 | 0.0500 |
| ▸2013 |
0.10 CNY
|
| Dec. 19, 2013 | 0.1000 |
| ▸2012 |
0.20 CNY
|
| Dec. 13, 2012 | 0.2000 |
| ▸2011 |
0.20 CNY
|
| July 6, 2011 | 0.2000 |
| ▸2006 |
0.14 CNY
|
| June 12, 2006 | 0.1406 |
| ▸2005 |
0.14 CNY
|
| June 29, 2005 | 0.1406 |
| ▸2004 |
0.14 CNY
|
| July 22, 2004 | 0.1406 |
| ▸2003 |
0.14 CNY
|
| July 28, 2003 | 0.1406 |
| ▸2002 |
0.16 CNY
|
| July 23, 2002 | 0.1594 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited | Jul 10, 2026 | Paid | 2.34 CNY |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited | Feb 12, 2026 | Paid | 2.45 CNY |
| Split Date | Split Ratio to 1 |
|---|---|
| July 18, 2006 | 1.28 |
| July 5, 2010 | 2:1 |
Community Discussion